About Us
ICD Pharma is developing Cannabis-based medicines, which will soon be available for patients and doctors around the world.
Our product pipeline includes Cannabis-based products in unique formulations, based on a portfolio of proprietary pharmaceutical delivery technologies, developed to address a variety of unmet clinical needs.
Based on many years of pharmaceutical development and with a track record of numerous drugs brought to market, we are creating a portfolio of best-in-class Cannabis-based therapies relying on novel formulations.
Our Vision
ICD Pharma's vision is to become a global leader in development of Cannabis based medicines for better, more effective and patient friendly care.
What we do
• Breakthrough technologies • Improved performance
• Better patient experience
What Patients Say
"It is always a battle to give Jane the oil, she dislikes the taste and when we mixed it with yogurt and other food, we never know how much she really consumes.
I wish there was non-oily, tasty syrup that she can take with a smile"
ICD Pharma Founders
Eran Tor
25 years of CEO and leadership experience in consumer brand and retail management around the world.
Alon Blankstein
25 years of CEO, and leadership experience in Startups, Incubator, Accelerator, and Corporate management.
Eran Perry
20 years of management and investment experience, life science
VC investments, entrepreneurship,
and big pharma.
Get in Touch
injecting Science into Cannabis and Improving Patients Care.
•
ICD Pharma